Stephen L. Monfre

Since 1995, Sensys Medical, Inc. (f.k.a. Instrumentation Metrics) has been diligently working on the development of a non-invasive blood glucose analyzer to assist those individuals with diabetes control their blood sugar levels. The Company intends to commercialize its Glucose Tracking System (GTSâ'¢), which will dramatically advance the practice of blood glucose monitoring and the science of diabetes disease management. Sensys Medical continues to advance the technologies necessary to successfully develop a device that is accurate, precise and simple to use in the hands of individuals. Sensys Medical scientists and engineers have furthered the understanding of non-invasive blood glucose measurement with advancements in the disciplines of tissue optics, multivariate statistics, optical engineering and analysis, detector materials, finite element analysis and applied computational fluid dynamics. These advances are continually tested in clinical trials and refined to ensure that individuals are capable of obtaining accurate non-invasive blood glucose measurements with minimal effort from the subject. As results from these trials become available, they will be shared through presentations and/or publications.

Part of Schneider Electric SE, Foxboro supplies automation solutions for the process industries.